NNNN (Anbio Biotechnology Class A Ordinary Shares) Stock Analysis - Insider Trades

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a publicly traded Healthcare sector company. As of May 21, 2026, NNNN trades at $31.00 with a market cap of $1.24B and a P/E ratio of 0.00. NNNN moved +2.57% today. Year to date, NNNN is -6.90%; over the trailing twelve months it is +298.00%. Its 52-week range spans $5.18 to $55.65. Rallies surfaces NNNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading NNNN stock inside the company?

Rallies tracks NNNN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

NNNN Key Metrics

Key financial metrics for NNNN
MetricValue
Price$31.00
Market Cap$1.24B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$55.65
52-Week Low$5.18
Volume110
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NNNN News

NNNN Analyst Consensus

NNNN analyst coverage data. Average price target: $0.00.

Common questions about NNNN

Who is trading NNNN stock inside the company?
Rallies tracks NNNN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for NNNN?
Yes. Rallies tracks NNNN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is NNNN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NNNN. It does not provide personalized investment advice.
NNNN

NNNN